Posts tagged “Layoffs”
Spoonflower, one of the Triangle's highest profile startups which raised $25 million last year and hired a top executive with IPO experience, has laid off 18 percent of its work force, the firm's president confirms to WRAL TechWire.
Just a year ago, Bull City Venture Partners invested in fast-growing Durham startup Spoonflower as part of a $25 million round. The company recently cut 18% of its work force. But BCVP's David Jones remains a big Spoonflower advocate.
In a leaked document, executives at IBM Netherlands describe how "Resource Balancing 2016" i.e. job cuts - are hitting that business group for the first time. The resource action, as IBM calls layoffs,could affect "several hundreds," a source tells Watching IBM at Facebook.
In today's wrapup of technology and life science news: Vice President Joe Biden threatens drug makers over trial information; Windows 10 gets an update; Dow Chemical to cut N.C. jobs; and China's top Internet regulator is replaced.
In today's Bulldog wrapup of technology news: HP Enterprise is selling its services group; Microsoft cuts jobs in mobile unit; Toyota decides to invest in Uber; and a new report says the federal government is spending billions on antiquated technology.
A new round of layoffs - the second in the last three months - is sweeping across IBM with numerous reports of job cuts at Big Blue's Research Triangle Park campus. IBM confirms cuts are being made but also says it has 25,000 open positions as it "aggressively" transforms the company. However, IBMers say few of those jobs are in the U.S.
In a wrapup of technology and life science news being reported by Triangle media outlets: TransEnterix cuts jobs after FDA rejects robot; G1 Therapeutics adds to a big fundraiser; and a look at the joint UNC-NCSU biomedical engineering effort.
INC Research's latest earnings report reflects growth in earnings, revenue and hiring. But a separate SEC filing discloses 175 layoffs as part of a reorganization. More are coming. Company execs also say they are using more contractors, which often are more expensive than full-time employees. What's going on? CROs such as INC, and Quintiles are battling for a particular kind of talent. They are known as CRAs.
BASF says its layoffs in Research Triangle Park are expected to affect "only 106 jobs," not as many as 190 as cited in a mass layoff filing with the state of North Carolina.
Argos Therapeutics, which is the midst of a crucial Phase 3 clinical trial, says it is cutting 13 percent of its work force to help cut costs. The company also says its chief operating officer is stepping down.
Analysis: Intel is turning from one legacy - a performance relying on chips for PCs - to a new one focusing on "cloud," mobile devices, 3D and other opportunities. As PC sales tumble, Intel is rebooting, and look for the tech giant to stabilize by mid-2017, says Technology Business Research analyst Krista Macomber.
A new research study from the Pew Research Center that charts public predictions on the future of workforce automation was released today. Nearly two-thirds of Americans expect that robots and computers will do much of the work currently done by humans.
Workers at IBM began telling the media through a Facebook site that Big Blue has started another round of layoffs on Wednesday. Later, the company confirmed that layoffs had begun in what it calls "workforce rebalancing." However, IBM also denied a report that it was cutting as much as one third of its workers in the U.S.
IBM, which recently sharply reduced severance pay packages for laid-off employees, is issuing layoff notices today to some workers in Research Triangle Park and at other U.S. locations, workers are telling the "Watching IBM" website. One called the cuts a "mass firing." IBM declines comment.
NetApp is cutting jobs at its big campus adjacent to Cisco in Research Triangle Park, but the storage tech company won't say how many. Despite the cuts, a NetApp spokesperson says the company remains committed to its N.C. operation.
Failure of a potential transplant treatment in a late-stage clinical trial triggered more than an 80 percent plunge in the price of Chimerix shares two months ago. The Durham drug development firm on Monday disclosed it had slashed its work force by 20 percent and also was cutting R&D spending.
- Scams & waste loom as charity millions donated after Orlando
- UK leader May, Cabinet to chart EU exit at Chequers retreat
- Uber, rival Careem suspend services in UAE capital Abu Dhabi
- German economy minister says EU-US trade talks have failed
- Holden Beach 10-year-old uses popcorn business to buy Christmas gifts for other kids